Llwytho...
Pancreatic cancer actionable genes and Precision Medicine and Personalized Surgery
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with an overall 5-year survival rate less than 5% due to the poor early diagnosis and lack of effective therapeutic options. The most effective therapy remains surgery, however post-operative survival could be enhanced with effective adjuvan...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Surgeon |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5195911/ https://ncbi.nlm.nih.gov/pubmed/27374183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surge.2016.05.002 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|